Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.
Culmination Bio has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.
Culmination Bio's investors include EPIC Ventures, Merck Global Health Innovation Fund, Amgen Ventures.
Culmination Bio is headquartered in Saint George, United States.
Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.
Culmination Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Culmination Bio — Funding & Investors." VCBacked, November 30, 2023, https://www.vcbacked.co/company/culmination-bio. Accessed August 1, 2026.
VCBacked. (2023). Culmination Bio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/culmination-bio
{{cite web |title=Culmination Bio — Funding & Investors |url=https://www.vcbacked.co/company/culmination-bio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated